General Information of the Compound
Compound ID
CP0105607
Compound Name
3-[1-(4-chlorophenyl)cyclopropyl]-8-propan-2-yl-[1,2,4]triazolo[4,3-a]pyridine
    Show/Hide
Structure
Formula
C18H18ClN3
Molecular Weight
311.816
Canonical SMILES
CC(C)c1cccn2c(nnc12)C1(CC1)c1ccc(Cl)cc1
    Show/Hide
InChI
InChI=1S/C18H18ClN3/c1-12(2)15-4-3-11-22-16(15)20-21-17(22)18(9-10-18)13-5-7-14(19)8-6-13/h3-8,11-12H,9-10H2,1-2H3
    Show/Hide
InChIKey
TVFMGTKSNWTWKN-UHFFFAOYSA-N
Physicochemical Property
logP
4.586
Rotatable Bonds
3
Heavy Atom Count
22
Polar Areas
30.19
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
3
Complexity
22

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 91039859
ChEMBL ID
CHEMBL3318979
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01107, 11-beta-hydroxysteroid dehydrogenase 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000065 HEK293-EBNA Homo sapiens (Human)  1
1
IC50 = 0.61 nM
   TI
   LI
   LO
   TS